- Home
- PBHC vs COYA Comparison
PBHC vs COYA Comparison
Compare PBHC & COYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBHC
- COYA
- Stock Information
- Founded
- PBHC 1859
- COYA 2020
- Country
- PBHC United States
- COYA United States
- Employees
- PBHC N/A
- COYA N/A
- Industry
- PBHC Major Banks
- COYA Biotechnology: Pharmaceutical Preparations
- Sector
- PBHC Finance
- COYA Health Care
- Exchange
- PBHC Nasdaq
- COYA Nasdaq
- Market Cap
- PBHC 93.1M
- COYA 107.0M
- IPO Year
- PBHC N/A
- COYA 2022
- Fundamental
- Price
- PBHC $14.92
- COYA $6.58
- Analyst Decision
- PBHC
- COYA Strong Buy
- Analyst Count
- PBHC 0
- COYA 4
- Target Price
- PBHC N/A
- COYA $16.50
- AVG Volume (30 Days)
- PBHC 3.3K
- COYA 68.8K
- Earning Date
- PBHC 10-29-2025
- COYA 08-12-2025
- Dividend Yield
- PBHC 2.68%
- COYA N/A
- EPS Growth
- PBHC N/A
- COYA N/A
- EPS
- PBHC 0.28
- COYA N/A
- Revenue
- PBHC $39,015,000.00
- COYA $423,452.00
- Revenue This Year
- PBHC N/A
- COYA N/A
- Revenue Next Year
- PBHC N/A
- COYA N/A
- P/E Ratio
- PBHC $53.16
- COYA N/A
- Revenue Growth
- PBHC N/A
- COYA N/A
- 52 Week Low
- PBHC $13.71
- COYA $4.65
- 52 Week High
- PBHC $19.86
- COYA $10.24
- Technical
- Relative Strength Index (RSI)
- PBHC 55.11
- COYA 59.51
- Support Level
- PBHC $14.40
- COYA $6.41
- Resistance Level
- PBHC $15.46
- COYA $7.30
- Average True Range (ATR)
- PBHC 0.18
- COYA 0.46
- MACD
- PBHC 0.06
- COYA 0.06
- Stochastic Oscillator
- PBHC 53.85
- COYA 72.36
About PBHC Pathfinder Bancorp Inc. (MD)
Pathfinder Bancorp Inc is a holding company for Pathfinder Bank. The Pathfinder Bank is a commercial bank engaged in attracting deposits from the general public and investing such deposits, together with other sources of funds, in loans secured by residential real estate, commercial real estate, small business loans, and consumer loans. The bank invests a portion of its assets in debt securities issued by the United States Government and its agencies and sponsored enterprises, state and municipal obligations, corporate debt securities, mutual funds, and equity securities. The principal source of income is interest on loans and investment securities.
About COYA Coya Therapeutics Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.